Department of Psychiatry, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.
Biol Psychiatry. 2013 May 1;73(9):843-50. doi: 10.1016/j.biopsych.2012.11.027. Epub 2013 Jan 8.
There is much interest in exploring whether reward-driven feeding can produce druglike plasticity in the brain. The gamma-aminobutyric acid (GABA) system in the nucleus accumbens (Acb) shell, which modulates hypothalamic feeding systems, is well placed to "usurp" homeostatic control of feeding. Nevertheless, it is unknown whether feeding-induced neuroadaptations occur in this system.
Separate groups of ad libitum-maintained rats were exposed to daily bouts of sweetened-fat intake, predator stress, or intra-Acb shell infusions of either d-amphetamine (2 or 10 μg) or the μ-opioid agonist D-[Ala2, N-MePhe4, Gly-ol]-enkephalin (DAMGO, 2.5 μg), then challenged with intra-Acb shell infusion of the GABAA agonist, muscimol (10 ng).
Exposure to sweetened fat robustly sensitized muscimol-induced feeding. Sensitization was present 1 week after cessation of the palatable feeding regimen but had abated by 2 weeks. Rats exposed to sweetened fat did not show an altered feeding response to food deprivation. Repeated intra-Acb shell infusions of DAMGO (2.5 μg) also sensitized intra-Acb shell muscimol-driven feeding. However, neither repeated intra-Acb shell d-amphetamine infusions (2 or 10 μg) nor intermittent exposure to an aversive stimulus (predator stress) altered sensitivity to muscimol.
Palatable feeding engenders hypersensitivity of Acb shell GABA responses; this effect may involve feeding-induced release of opioid peptides. Heightened arousal, aversive experiences, or increased catecholamine transmission alone are insufficient to produce the effect, and a hunger-induced feeding drive is insufficient to reveal the effect. These findings reveal a novel type of food-induced neuroadaptation within the Acb; possible implications for understanding crossover effects between food reward and drug reward are discussed.
探索奖赏驱动的进食是否会在大脑中产生类似药物的可塑性,这引起了广泛关注。调节下丘脑进食系统的伏隔核(Acb)壳中的γ-氨基丁酸(GABA)系统,很适合“篡夺”进食的稳态控制。然而,目前尚不清楚该系统是否会发生进食诱导的神经适应性变化。
分别将自由摄食的大鼠暴露于每日摄入含糖高脂肪的饮食、捕食者应激或 Acb 壳内的 d-苯丙胺(2 或 10 μg)或 μ-阿片样物质激动剂 D-[Ala2,N-MePhe4,Gly-ol]-脑啡肽(DAMGO,2.5 μg)的单次输注中,然后用 Acb 壳内的 GABAA 激动剂,muscimol(10 ng)进行挑战。
摄入含糖高脂肪饮食可显著敏化 muscimol 诱导的进食。在美味饮食方案停止后 1 周即可观察到敏化,2 周后敏化消失。摄入含糖高脂肪饮食的大鼠对食物剥夺没有表现出改变的进食反应。重复 Acb 壳内 DAMGO(2.5 μg)输注也敏化了 Acb 壳内 muscimol 驱动的进食。然而,反复 Acb 壳内 d-苯丙胺(2 或 10 μg)输注或间歇性暴露于厌恶刺激(捕食者应激)均未改变 muscimol 的敏感性。
美味饮食会引起 Acb 壳 GABA 反应的超敏性;这种效应可能涉及进食诱导的阿片肽释放。单独增加觉醒、产生厌恶经验或增加儿茶酚胺传递不足以产生这种效应,而饥饿引起的进食驱动力不足以揭示这种效应。这些发现揭示了 Acb 内一种新型的食物诱导的神经适应性变化;讨论了其对理解食物奖励和药物奖励之间交叉效应的可能意义。